Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage

NCT05731375 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05731375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05731375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Completed
Start date
December 28, 2023
Completion date
March 20, 2026
Enrollment
12 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anthracyclines, chemotherapeutic toxicity, doxorubicin induced cardiomyopathy